StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) shareholders

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.1%
2M of 1.71B shares
Institutional holders
8
1 new, 0 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of NWBOValueChange% of portfolio
Compass Financial Management LLC1,215,5000.07%$227.07KNew0.03%
Wall Street Access Asset Management, LLC800,0000.05%$149.44K+600,0000.02%
VSM Wealth Advisory, LLC80,5740.00%$15.05K–0.00%
Opus Capital Group, LLC60,1500.00%$11.00K–0.00%
Ethos Financial Group, LLC39,0700.00%$6.33K–0.00%
Williams Jones Wealth Management, LLC.25,0000.00%$4.67K–0.00%
Coston, McIsaac & Partners1,0000.00%$0–0.00%
Hantz Financial Services, Inc.2500.00%$0–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202682M0.1%1 / 10 / 02M0M
Q1 202680M0.0%2 / 11 / 10M0M
Q4 202570M0.0%0 / 20 / 10M0M
Q3 202591M0.0%0 / 11 / 00M0M
Q2 202591M0.0%1 / 20 / 00M0M
Q1 202581M0.0%0 / 10 / 20M0M
Q4 2024111M0.0%2 / 11 / 20M0M
Q3 2024111M0.0%0 / 10 / 20M0M
Q2 2024131M0.0%3 / 11 / 00M0M
Q1 2024101M0.0%3 / 11 / 10M0M
Q4 2023101M0.0%0 / 10 / 10M0M
Q3 2023111M0.0%1 / 10 / 00M0M

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Navid Malik
Director
Nov 17, 2023Sale+150,000$0.82$123.00K295,000
Navid Malik
Director
Nov 17, 2023Sale+295,000$0.82$241.90K0
Navid Malik
Director
Nov 16, 2023Sale+125,000$0.84$105.00K445,000
Marnix L. Bosch
Chief Technical Officer
Apr 3, 2023Award+119,355$0.25$29.84K119,355
Jerry J. Jasinowski
Director
Dec 1, 2022Award+28,235$21.25$599.99K28,235
Jerry J. Jasinowski
Director
Feb 3, 2020Award+526,316$0.19$100.00K1,891,347
Linda F. Powers
President and CEO, Director, 10% owner
Dec 28, 2018Sale−804,146$0.17$136.70K0
Linda F. Powers
President and CEO, Director, 10% owner
Dec 27, 2018Sale−3,558,639$0.17$604.97K29,411,760
Cognate Bioservices, Inc.
10% owner
Jun 30, 2015Sale−1,118,092$4.22$4.72M18,460,390
Cognate Bioservices, Inc.
10% owner
Jun 30, 2015Sale−650,000$4.00$2.60M19,578,482
Toucan General II, LLC
10% owner
Sep 15, 2014Sale−149,502$5.02$750.50K20,228,482
Toucan General II, LLC
10% owner
Sep 15, 2014Sale−149,502$5.02$750.50K20,228,482
Toucan General II, LLC
10% owner
Sep 1, 2014Buy+639,108––20,377,984
Toucan General II, LLC
10% owner
Sep 1, 2014Buy+639,108––20,377,984
Toucan General II, LLC
10% owner
Aug 27, 2014Sale−145,068$5.17$750.00K19,738,876
Toucan General II, LLC
10% owner
Aug 27, 2014Sale−145,068$5.17$750.00K19,738,876
Robert A. Farmer
Director
Aug 1, 2014Buy+3,013$5.60$16.87K135,417
Toucan General II, LLC
10% owner
Aug 1, 2014Buy+550,219––19,883,944
Toucan General II, LLC
10% owner
Aug 1, 2014Buy+550,219––19,883,944
Toucan General II, LLC
10% owner
Jul 1, 2014Buy+796,879––19,333,725
Toucan General II, LLC
10% owner
Jul 1, 2014Buy+796,879––19,333,725
Toucan General II, LLC
10% owner
Jun 30, 2014Buy+562,500––18,536,847
Toucan General II, LLC
10% owner
Jun 30, 2014Buy+562,500––18,536,847
Toucan General II, LLC
10% owner
Jun 1, 2014Buy+385,320––17,974,347
Toucan General II, LLC
10% owner
Jun 1, 2014Buy+385,320––17,974,347
Toucan General II, LLC
10% owner
May 1, 2014Buy+341,971––17,589,027
Toucan General II, LLC
10% owner
May 1, 2014Buy+341,971––17,589,027
Toucan General II, LLC
10% owner
Apr 1, 2014Buy+289,531––17,247,056
Toucan General II, LLC
10% owner
Apr 1, 2014Buy+289,531––17,247,056
Toucan General II, LLC
10% owner
Mar 7, 2014Sale−133,333$3.64$485.33K17,077,895
Toucan General II, LLC
10% owner
Mar 7, 2014Sale−120,370$3.64$438.15K16,957,525
Toucan General II, LLC
10% owner
Mar 7, 2014Sale−120,370$3.64$438.15K16,957,525
Toucan General II, LLC
10% owner
Mar 7, 2014Sale−133,333$3.64$485.33K17,077,895
Toucan General II, LLC
10% owner
Mar 1, 2014Buy+389,611––17,211,228
Toucan General II, LLC
10% owner
Mar 1, 2014Buy+389,611––17,211,228
Toucan General II, LLC
10% owner
Feb 8, 2014Sale−79,630$3.09$246.06K16,821,617
Robert F. Hemphill Jr.
10% owner
Feb 8, 2014Sale−79,630$3.09$246.06K16,821,617
Toucan General II, LLC
10% owner
Feb 7, 2014Sale−132,540$3.09$409.55K16,901,247
Robert F. Hemphill Jr.
10% owner
Feb 7, 2014Sale−132,540$3.09$409.55K16,901,247
Toucan General II, LLC
10% owner
Feb 4, 2014Sale−233,344$3.21$749.03K17,033,787
Robert F. Hemphill Jr.
10% owner
Feb 4, 2014Sale−233,344$3.21$749.03K17,033,787
Toucan General II, LLC
10% owner
Feb 1, 2014Buy+500,000––16,980,076
Toucan General II, LLC
10% owner
Feb 1, 2014Buy+287,055––17,267,131
Robert F. Hemphill Jr.
10% owner
Feb 1, 2014Buy+500,000––16,980,076
Robert F. Hemphill Jr.
10% owner
Feb 1, 2014Buy+287,055––17,267,131
Toucan General II, LLC
10% owner
Jan 31, 2014Sale−233,344$3.21$749.03K16,480,076
Robert F. Hemphill Jr.
10% owner
Jan 31, 2014Sale−233,344$3.21$749.03K16,480,076
Toucan General II, LLC
10% owner
Jan 17, 2014Buy+5,101,366––16,713,420
Robert F. Hemphill Jr.
10% owner
Jan 17, 2014Buy+5,101,366––16,713,420
Toucan General II, LLC
10% owner
Jan 1, 2014Buy+238,248––11,612,054
Robert F. Hemphill Jr.
10% owner
Jan 1, 2014Buy+238,248––11,612,054
Toucan General II, LLC
10% owner
Dec 31, 2013Other+1,330,057––11,373,806
Robert F. Hemphill Jr.
10% owner
Dec 31, 2013Other+1,330,057––11,373,806
Navid Malik
Director
Dec 17, 2013Buy+10,000––10,000
Robert A. Farmer
Director
Dec 4, 2013Buy+132,404$5.60$741.46K132,404
Toucan General II, LLC
10% owner
Dec 1, 2013Buy+277,199––10,043,749
Robert F. Hemphill Jr.
10% owner
Dec 1, 2013Buy+277,199––10,043,749
Robert F. Hemphill Jr.
10% owner
Nov 1, 2013Buy+257,439––9,766,550
Robert F. Hemphill Jr.
10% owner
Oct 31, 2013Buy+223,042––9,509,111
Robert F. Hemphill Jr.
10% owner
Jul 31, 2013Buy+2,902,072$4.00$11.61M9,286,069

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
69M shares short
Days to cover
7.8
At 9M shares a day
Change since last report
-5.1%
From 73M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Northwest Biotherapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,955,150 shares on Oct 13, 2026 over the last 90 days.

See a number that looks wrong?